Back to search

Striatal dopamine deficiency in parkinson's disease: Role of aging

Data up to Jan 2025

Published1989
Citations266
References27

Total Citations Per Year

Abstract

References (27)

A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding

1976 • 225,752 citations

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1976 • 200,127 citations

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations

1973 • 2,615 citations

Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen Systems

1960 • 1,863 citations

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

1988 • 1,235 citations

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

1983 • 712 citations

Aging and Extrapyramidal Function

1977 • 650 citations

Time course of nigrostriatal degeneration in parkinson's disease

1976 • 561 citations

Handbook of Experimental Pharmacology, vol 14.

1972 • 446 citations

Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine Levels in human basal ganglia

1976 • 328 citations

ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AND MOTONEURONE DISEASE: ABIOTROPIC INTERACTION BETWEEN AGEING AND ENVIRONMENT?

1986 • 257 citations

Post-mortem distribution of dopamine and homo-vanillic acid in human brain, variations related to age, and a review of the literature

1979 • 218 citations

Benzoquinolizine Derivatives: a New Class of Monamine Decreasing Drugs With Psychotropic Action

1962 • 170 citations

Characterization of the monoamine carrier of chromaffin granule membrane by binding of [2-3H]dihydrotetrabenazine.

1983 • 126 citations

Parkinsons disease and its chemotherapy

1975 • 113 citations

Does levodopa aggravate Parkinson's disease?

1988 • 104 citations

Dihydrotetrabenazine Binding and Monoamine Uptake in Mouse Brain Regions

1986 • 100 citations

[3H]Dihydrotetrabenazine, a New In Vitro Monoaminergic Probe for Human Brain

1988 • 84 citations

Brain Catecholamines and Their Metabolites in Parkinsonian Patients

1973 • 75 citations

Postmortem stability of norepinephrine, dopamine, and serotonin in rat brain

1977 • 54 citations

The regionalization of [3H]dihydrotetrabenazine binding sites in the mouse brain and its relationship to the distribution of monoamines and their metabolites

1986 • 48 citations

Postmortem Changes in Catecholamines, Indoleamines, and Their Metabolites in Rat Brain Regions: Prevention with 10‐kW Microwave Irradiation

1985 • 48 citations

Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by mass gragmentography

1974 • 42 citations

[3H]Dihydrotetrabenazine binding to bovine striatal synaptic vesicles.

1986 • 39 citations

Nerve Cell Death in Degenerative Diseases of the Central Nervous System: Clinical Aspects

2007 • 39 citations

Postmortem Changes in Brain Catecholamine Enzymes

1975 • 34 citations

Characterization of the vesicular monoamine transporter in cultured rat sympathetic neurons: Persistence upon induction of cholinergic phenotypic traits

1987 • 18 citations

Cited By (0)

No citing papers found in database

Striatal dopamine deficiency in parkinson's disease: Role of aging (1989) – Annals of Neurology | Metascience Observatory Explorer